Sun Pharma launches Kapspargo Sprinkle formulation in US

New Delhi: Drug major Sun Pharmaceutical Industries said it has launched Kapspargo Sprinkle (metoprolol succinate) extended-release capsules used for the treatment of hypertension, chest pain and heart failure in the US market.
Kapspargo Sprinkle pellets can be sprinkled over soft food or administered via a nasogastric tube, and are designed to facilitate long-term, once-daily administration, particularly for patients who have difficulty swallowing, Sun Pharma said in a BSE filing.
Sun Pharma North America CEO Abhay Gandhi said: "Kapspargo Sprinkle capsules may make it easier for patients to take their antihypertensive medication."
This innovative product is the latest example of Sun Pharma's use of advanced technology to create novel formulations of proven medications, he added.
Abhay Gandhichest painformulationheart failurehypertensionKapspargo SprinkleKapspargo Sprinkle extended-release capsulesKapspargo Sprinkle pelletslaunchesmetoprolol succinatenasogastric tubesoft foodSun PharmaSun Pharmaceutical IndustriesUSUS market
Source : PTINext Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd